These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3344680)

  • 21. Double-blind placebo-controlled evaluation of propafenone in suppressing ventricular ectopic activity.
    Hodges M; Salerno D; Granrud G
    Am J Cardiol; 1984 Nov; 54(9):45D-50D. PubMed ID: 6388303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiform ventricular complexes: a transitional arrhythmia form?
    Kessler KM; McAuliffe D; Chakko CS; Castellanos A; Myerburg RJ
    Am Heart J; 1989 Sep; 118(3):441-4. PubMed ID: 2476017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of sotalol for therapy of complex ventricular arrhythmias and comparisons with placebo and class I antiarrhythmic drugs.
    Anderson JL
    Am J Cardiol; 1990 Jan; 65(2):37A-42A; discussion 51A-52A. PubMed ID: 2403734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Management of supraventricular and ventricular arrhythmias with the intravenous administration of the calcium antagonist Tiapamil (Ro 11-1781) (author's transl)].
    Menzel T; Kirchner P; Cocco G; Gasser DF
    Z Kardiol; 1981 Mar; 70(3):163-71. PubMed ID: 6165153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rate-dependent effects of procainamide on His-Purkinje conduction in man.
    Gang ES; Denton TA; Oseran DS; Mandel WJ; Peter T
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1525-9. PubMed ID: 4003294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive value of ventricular arrhythmias in resuscitated out-of-hospital cardiac arrest victims.
    Temesy-Armos PN; Medendorp SV; Goldstein S; Landis JR; Leighton RF; Ritter G; Vasu CM; Wolfe RA; Acheson A
    Eur Heart J; 1988 Jun; 9(6):625-33. PubMed ID: 3409893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: comparison with procainamide.
    Roden DM; Reele SB; Higgins SB; Wilkinson GR; Smith RF; Oates JA; Woosley RL
    Am J Cardiol; 1980 Sep; 46(3):463-8. PubMed ID: 6158263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ventricular arrhythmias and risk of death and acute myocardial infarction in apparently healthy subjects of age >or=55 years.
    Sajadieh A; Nielsen OW; Rasmussen V; Hein HO; Frederiksen BS; Davanlou M; Hansen JF
    Am J Cardiol; 2006 May; 97(9):1351-7. PubMed ID: 16635610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiarrhythmic efficacy of Ethmozine (moricizine HCl) compared with disopyramide and propranolol.
    Pratt CM; Butman SM; Young JB; Knoll M; English LD
    Am J Cardiol; 1987 Oct; 60(11):52F-58F. PubMed ID: 3310586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiarrhythmic efficacy of N-acetylprocainamide in patients with premature ventricular contractions.
    Lee WK; Strong JM; Kehoe RF; Dutcher JS; Atkinson AJ
    Clin Pharmacol Ther; 1976 May; 19(5 Pt 1):508-14. PubMed ID: 776488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Recent progress in analysis of arrhythmias using electrocardiography].
    Fujino T; Ishida S; Takahashi N; Nakagawa M; Ito M; Saikawa T
    Rinsho Byori; 1993 Apr; 41(4):426-32. PubMed ID: 7688834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The associations of levels of serum potassium and magnesium with ventricular premature complexes (the Framingham Heart Study).
    Tsuji H; Venditti FJ; Evans JC; Larson MG; Levy D
    Am J Cardiol; 1994 Aug; 74(3):232-5. PubMed ID: 7518645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and tolerance of intravenous lorcainide in patients with normal and impaired intraventricular conduction.
    Stroobandt R; Kesteloot H
    Acta Cardiol; 1985; 40(6):637-48. PubMed ID: 3879420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-blind, crossover comparison of flecainide acetate and disopyramide phosphate in the treatment of ventricular premature complexes.
    Kjekshus J; Bathen J; Orning OM; Storstein L
    Am J Cardiol; 1984 Feb; 53(5):72B-78B. PubMed ID: 6421140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of procainamide and mexiletine in prevention of ventricular arrhythmias after acute myocardial infarction.
    Campbell RW; Dolder MA; Prescott LF; Talbot RG; Murray A; Julian DG
    Lancet; 1975 Jun; 1(7919):1257-60. PubMed ID: 48894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exacerbation of coronary occlusion induced ventricular arrhythmias by the vagolytic effect of procainamide.
    Corr PB; Helke CJ; Gillis RA
    Cardiovasc Res; 1978 Aug; 12(8):486-92. PubMed ID: 719661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical implication of surface morphology of ventricular premature contractions.
    Sharma PR; Chung EK
    J Electrocardiol; 1980 Oct; 13(4):331-6. PubMed ID: 7430860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of ivabradine and beta-blocker therapy on dobutamine-induced ventricular arrhythmias.
    Mert KU; Mert GÖ; Morrad B; Tahmazov S; Mutlu F; Çavuşoglu Y
    Kardiol Pol; 2017; 75(8):786-793. PubMed ID: 28541596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ventricular arrhythmias before and late after aortic valve replacement.
    von Olshausen K; Amann E; Hofmann M; Schwarz F; Mehmel HC; Kübler W
    Am J Cardiol; 1984 Jul; 54(1):142-6. PubMed ID: 6741805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The assessment of an antiarrhythmic agent, sustained-release procainamide, with the aid of Holter monitoring.
    Bauer GE; Mitchell AS; Bates F; Hellestrand K
    Med J Aust; 1977 Nov; 2(22):733-5. PubMed ID: 347229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.